MedTrace Logo

Interleukin (IL)-13 as a Marker in Pediatrics Asthma

NCT00968305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2009-08-28

No results posted yet for this study

Summary

Asthma is a very common childhood chronic illness and is generally more severe in African Americans. The investigators attempted to determine whether a specific immune marker is associated with lung function and asthma severity.

Conditions

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Byung H Yu, MD · Rush University Medical Center, Department of Immunology and Microbiology

Eligibility

Min Age
8 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00968305 on ClinicalTrials.gov